Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors' therapeutic outcomes for non-small cell lung cancer

CONCLUSION: The frequency and proportion of ctDNA mutations are worth clinical attention in the prediction of therapeutic outcomes.PMID:35578031 | DOI:10.1007/s00432-022-03992-5

Source: Clinical Lung Cancer - May 16, 2022 Category: Cancer & Oncology Authors: Jiajia Song Ling Bai Jianzhao Zhai Zhaodan Xin Liting You Yi Zhou Juan Zhou Binwu Ying Source Type: research